DAFTAR PUSTAKA
1. Yogiantoro, Mohammad. Hipertensi Esensial. In: Sudoyo dkk (ed). Buku Ajar Ilmu Peyakit Dalam Jilid I Edisi IV. Jakarta: FKUI. 2006, pp: 610-14.
2. WHO.A Global Brief on Hypertension. Geneva: WHO Press. 2013, pp:8-15.
3. Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar (RISKESDAS) 2013. Kementrian Kesehatan Republik Indonesia, 2013.
4. Oh, Young S. Galis, Zorina S. Anatomy of Success: The Top 100 Cited Scientific Reports Focused On Hypertension Research. Dallas: American Heart Association, 2013.
5. Youssef, Magda HM. Is Hyperuricemia a Risk Factor to Cardiovascular Disease. In: Cairo: Gaze, David C. Ischemic Heart Disease. InTech. 2013:123-31.
6. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102-110.
7. Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol. 2007;18:287-292.
8. Feig, Daniel I. Hyperuricemia and Hypertension. In: National Kidney Foundation. Advances in Chronic Kidney Disease. 2012;19 (6): 377-385.
9. Lozada, Laura GS. Mild Hyperuricemia Induces Vasoconstriction and Maintains Glomerular Hypertension in Normal and Remnant Kidney Rats. In: Kidney International,2005;67:237–247.
11. Kaishusha, David Salama, Philippe Bianga Katchunga. Study on the relationship between hypertension and hyperuricemia in a group of patient in South Kivu, democratic republic of Congo. Journal of Clinical & Experimental Cardiology. 2014 April;5(3).
12. Mustafiza, Pramadya V. Hubungan Antara Hiperurisemia dengan Hipertensi. Surakarta: Fakultas Kedokteran Universitas Sebelas Maret. 2010.
13. Sherwood, L. Fisiologi Manusia dari Sel ke Sistem. Diterjemahkan oleh : Brahm U. Jakarta : EGC. 2001.
14. Prodjosudjadi, W. Masa Depan Hipertensi dan PGK di Indonesia. Dalam: Lubis, H.R. 2008.Hipertensi dan Ginjal. USU Press, Medan. 2008, pp: 123-130.
15. Julius, S. 2008. Clinical implications of pathophysiologic changes in the midlife hypertensive patients. American Heart Journal, 122: 886-891.
16. Gray Huon H, Dawkins KD, Morgan JM, Simpson IA. Hipertensi dalam: Lecture Notes Kardiologi Edisi ke-4. Jakarta: Erlangga. 2005, pp:57-62
17. Putra, Tjokorda Raka. Hiperurisemia. In: Sudoyo dkk (ed). Buku Ajar Ilmu Peyakit Dalam Jilid II Edisi IV. Jakarta: FKUI. 2006, pp: 1213-17.
18. Vitahealth.Asam Urat. Jakarta , PT Gramedia Pustaka Utama. 2006.
19. Kertia Nyoman.Asam urat. Kartika Media: Yogyakarta, 2009.
20. Poedjiadi, A.Dasar–Dasar Biokimia.Edisi Revisi. Jakarta: UI - Press, 2006.
21. Kumar V, Cotran R, Robbins S. Buku Ajar Patologi Robbins 7th ed. Jakarta: EGC; 2006, pp: 864-8.
23. Feig Daniel I, Soletsky B, Johnson RJ. Effect of Allopurinol on Blood Pressure of Adolescents with Newly Diagnosed Essential Hypertension. JAMA. 2008: 924-932.
24. Aiyer, Kala JV, Michael Alderman. Uric acid: role in cardiovascular disease and effects of losartan. Current Medical Research and Opinion. 2004 Mar;20(3):369-79.
25. Paula, Jayanta, Somnath Dasgupta.Association of hyperuricemia with carotid intima-media thickness, albuminuria, diabetes, hypertension in chronic renal failure. World Journal of Nephrology and Urology. 2012 June;1(2-3):66-72.
26. Jules Clement Nguedia Assob1, Marcelin Ngowe, Dickson Shey Nsagha, Anna Longdoh Njunda, Yvonne Waidim, Dieudonné Njimoh Lemuh and Elroy Patrick Weledji.The relationship between uric acid and hypertension in adults in Fako Division, SW region Cameroon. Journal of Nutrition and Food Science 2014: 4(1).
27. S Ouppatham, S Bancha, P Choovichian. The relationship of hyperuricemia and blood pressure in the Thai army population. J Postgrad Med. 2008 Oct-Dec;54(4), pp: 259-62.
28. Feig Daniel I, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney International. 2004 Jul;66(1), pp:281-7.
29. Aminullah A, Rukman Y, Munasir Z, Sastroasmoro S. Dasar – Dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta: Sagung Seto. 2007, pp:255-78.
30. Azwar, Azrul dan Joedo Prihartono. Metodologi Penelitian Kedokteran dan Kesehatan Masyarakat, Jakarta:Binurupa Aksara. 2003.
32. Murti, Bhisma. Desain dan Ukuran Sampel untuk Penelitian Kuantitatif dan Kualitatif di Bidang Kesehatan. Yogyakarta : Gadjah Mada University Press, 2010.
33. Sastroasmoro, Sudigdo. Pengukuran dalam Penelitian. In: Sastroasmoro S dan Ismael S (ed). Dasar– Dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta: Sagung Seto. 2007, pp: 78-91.
34. Kuncoro, Ahmad, Engkos, Ridwan, Analisis Jalur (Path Analisis) Edisi kedua, Bandung: Penerbit Alfabeta. 2008, pp:61-62.
35. Humayun A, Shah AS, Sultana R. Relation of hypertension with body mass index and age in male and female population of Peshawar, Pakistan. J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):63-5.
36. Mungreiphy NK, Kapoor S, Sinha R. Association between BMI, Blood Pressure, and Age: Study among angkhul Naga TribalMales of Northeast India. Journal of Anthropology. 2011:ID748147.
37. Landahl S, Bengtsson C, Sigurdsson JA, Svanborg A, Svärdsudd K. Age-related changes in blood pressure. Hypertension. 1986 Nov;8(11):1044-9.
38. Heryudarini H, Hardinsyah, Budi S, Imam E. Hubungan indeks massa tubuh, jenis kelamin, usia, golongan darah dan riwayat keturunan dengan tekanan darah pada pegawai negeri di pekan baru. Jurnal Penelitian Gizi dan Makanan. 2008; 31(2).
39. Yulyius. Hubungan antara status gizi dengan tekanan darah mahasiswa program studi pendidikan dokter angkatan 2013 fakultas kedokteran universitas sam ratulangi.Jurnal e-Biomedik. 2014;Vol 2(1).
41. Brands MW, Hall JE, Van Vliet BN, Alonso-Galicia M, Herrera GA, Zappe D. Obesity and hypertension: roles of hyperinsulinemia, sympathetic nervous system and intrarenal mechanisms. J Nutr. 1995 Jun;125(6 Suppl):1725S-1731S.
42. Prasad DS, Kabir Z, Dash AK, Das BC. Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: A clinico-epidemiological evidence summary. J Cardiovasc Dis Res. 2011 Oct;2(4):199-205.
43. Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L. Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive. BMC Cardiovasc Disord 2012, 12:3.
44. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010; 62:170–80.
45. De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis 2010;69:1162–4.
46. Wheeler JG, Juzwishin KD, Eiriksdottir G, Gudnason V, Danesh J, Wheeler JG, et al. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Medicine / Public Library of Science. 2005;2(3):e76.
47. Klein R, Klein BE, Cornoni JC, Maready J, Cassel J, Tyroler HA. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973;132:401–10.
48. Brand FN, McGee DL, Kannel WB, Stokes J III, Castelli WP.Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985;121:11–8.
50. Zhang W1, Sun K, Yang Y, Zhang H, Hu FB, Hui R. Plasma uric acid and hypertension in a Chinese community: prospective study and meta-analysis. Clin Chem. 2009 Nov;55(11):2026-34.
51. Hayden MR, Tyagi SC. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 2004;1:10.
52. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006;19:1055–62.
